Skip to results
Modify your search
NARROW
1-9 of 9
Authors: Lauren Grant
Sort by
Journal Article
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months–4 Years, United States, September 2022–April 2023
Get access
Leora R Feldstein and others
Journal of the Pediatric Infectious Diseases Society, Volume 14, Issue 1, January 2025, piae121, https://doi.org/10.1093/jpids/piae121
Published: 05 December 2024
Journal Article
Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022–2023: A Prospective Cohort Study
Get access
Elizabeth B White and others
Clinical Infectious Diseases, Volume 80, Issue 4, 15 April 2025, Pages 893–900, https://doi.org/10.1093/cid/ciae491
Published: 24 October 2024
Journal Article
Relative Effectiveness and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Versus Egg-Based Inactivated Influenza Vaccine Among Adults Aged 18–64 Years: Results and Experience From a Randomized, Double-Blind Trial
Lauren Grant and others
Open Forum Infectious Diseases, Volume 11, Issue 10, October 2024, ofae559, https://doi.org/10.1093/ofid/ofae559
Published: 26 September 2024
Journal Article
Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5–11 Years in a Multisite Prospective Cohort Study, September 2021–September 2022
Zoe L Lyski and others
Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad431, https://doi.org/10.1093/ofid/ofad431
Published: 12 August 2023
Journal Article
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture–Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18–65 Years in 2019–2020
Allison L Naleway and others
Open Forum Infectious Diseases, Volume 10, Issue 6, June 2023, ofad223, https://doi.org/10.1093/ofid/ofad223
Published: 21 April 2023
Journal Article
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses
Meghan K Herring and others
Clinical Infectious Diseases, Volume 76, Issue 10, 15 May 2023, Pages 1822–1831, https://doi.org/10.1093/cid/ciac976
Published: 29 December 2022
Journal Article
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial
Manjusha Gaglani and others
Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e1168–e1176, https://doi.org/10.1093/cid/ciac683
Published: 29 August 2022
Journal Article
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection
Harmony L Tyner and others
Clinical Infectious Diseases, Volume 75, Issue 1, 1 July 2022, Pages e827–e837, https://doi.org/10.1093/cid/ciab1038
Published: 20 December 2021
Journal Article
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized Open-Label Trial
Fatimah S Dawood and others
Clinical Infectious Diseases, Volume 73, Issue 11, 1 December 2021, Pages 1973–1981, https://doi.org/10.1093/cid/ciab566
Published: 10 July 2021